Literature DB >> 36268245

18F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N- and M-staging: should guidelines recommend it at last?

Maurizio Zizzo1, Magda Zanelli2, Francesca Sanguedolce3, Annibale Versari4, Pierpaolo Pattacini5, Andrea Morini1, Federica Mereu1, Antonia Lavinia Zuliani1, Alessandro Giunta1.   

Abstract

Entities:  

Year:  2022        PMID： 36268245      PMCID： PMC9577986          DOI： 10.21037/hbsn-22-273

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  13 in total

Review 1.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 2.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors:  John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

4.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J W Valle; I Borbath; S A Khan; F Huguet; T Gruenberger; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

5.  Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging.

Authors: 
Journal:  Dig Liver Dis       Date:  2020-09-04       Impact factor: 4.088

6.  18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.

Authors:  Angela Lamarca; Jorge Barriuso; Amarjot Chander; Mairéad G McNamara; Richard A Hubner; Derek ÓReilly; Prakash Manoharan; Juan W Valle
Journal:  J Hepatol       Date:  2019-02-21       Impact factor: 25.083

7.  The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.

Authors:  Zhi Ven Fong; Sarah A Brownlee; Motaz Qadan; Kenneth K Tanabe
Journal:  Ann Surg Oncol       Date:  2021-03-01       Impact factor: 5.344

8.  Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition.

Authors:  Masato Nagino; Satoshi Hirano; Hideyuki Yoshitomi; Taku Aoki; Katsuhiko Uesaka; Michiaki Unno; Tomoki Ebata; Masaru Konishi; Keiji Sano; Kazuaki Shimada; Hiroaki Shimizu; Ryota Higuchi; Toshifumi Wakai; Hiroyuki Isayama; Takuji Okusaka; Toshio Tsuyuguchi; Yoshiki Hirooka; Junji Furuse; Hiroyuki Maguchi; Kojiro Suzuki; Hideya Yamazaki; Hiroshi Kijima; Akio Yanagisawa; Masahiro Yoshida; Yukihiro Yokoyama; Takashi Mizuno; Itaru Endo
Journal:  J Hepatobiliary Pancreat Sci       Date:  2020-12-23       Impact factor: 7.027

Review 9.  Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma.

Authors:  Jiong Liu; Wen Xiu Ren; Jian Shu
Journal:  Insights Imaging       Date:  2022-01-20

10.  Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.

Authors:  Xujian Huang; Jialin Yang; Jingdong Li; Yongfu Xiong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.